Insufficient scRNA-seq data for expression of MMP1 at single-cell level.
Insufficient scRNA-seq data for expression of MMP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 91% | 2547.48 | 328 / 359 | 78% | 170.42 | 223 / 286 |
lung | 74% | 527.30 | 430 / 578 | 73% | 245.30 | 847 / 1155 |
pancreas | 43% | 97.09 | 142 / 328 | 84% | 439.26 | 149 / 178 |
intestine | 49% | 339.14 | 472 / 966 | 76% | 218.70 | 401 / 527 |
bladder | 43% | 144.81 | 9 / 21 | 59% | 189.21 | 298 / 504 |
esophagus | 13% | 133.73 | 194 / 1445 | 86% | 305.56 | 158 / 183 |
spleen | 93% | 186.68 | 225 / 241 | 0% | 0 | 0 / 0 |
kidney | 66% | 73.30 | 59 / 89 | 8% | 13.10 | 69 / 901 |
skin | 38% | 4487.29 | 682 / 1809 | 29% | 72.52 | 137 / 472 |
tonsil | 0% | 0 | 0 / 0 | 58% | 206.03 | 26 / 45 |
uterus | 6% | 4.36 | 10 / 170 | 46% | 113.08 | 210 / 459 |
breast | 11% | 15.85 | 49 / 459 | 33% | 48.17 | 364 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 24% | 63.01 | 7 / 29 |
prostate | 22% | 31.31 | 54 / 245 | 0% | 0.09 | 1 / 502 |
thymus | 17% | 16.11 | 112 / 653 | 1% | 0.39 | 6 / 605 |
adipose | 18% | 16.56 | 214 / 1204 | 0% | 0 | 0 / 0 |
heart | 14% | 17.19 | 120 / 861 | 0% | 0 | 0 / 0 |
ovary | 2% | 1.04 | 3 / 180 | 11% | 8.21 | 46 / 430 |
peripheral blood | 12% | 16.09 | 113 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 10% | 13.76 | 139 / 1335 | 0% | 0 | 0 / 0 |
liver | 7% | 59.46 | 16 / 226 | 3% | 3.69 | 12 / 406 |
adrenal gland | 4% | 5.07 | 11 / 258 | 3% | 5.62 | 8 / 230 |
brain | 1% | 0.78 | 37 / 2642 | 1% | 0.52 | 6 / 705 |
muscle | 1% | 0.92 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0030574 | Biological process | collagen catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0071492 | Biological process | cellular response to UV-A |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0019538 | Biological process | protein metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | MMP1 |
Protein name | Alternative protein MMP1 Interstitial collagenase (EC 3.4.24.7) (Fibroblast collagenase) (Matrix metalloproteinase-1) (MMP-1) [Cleaved into: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase] Matrix metalloproteinase 1 interstitial collagenase (EC 3.4.24.7) |
Synonyms | CLG |
Description | FUNCTION: Cleaves collagens of types I, II, and III at one site in the helical domain. Also cleaves collagens of types VII and X . In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity . . |
Accessions | A5GZ69 L8EC95 P03956 ENST00000315274.7 Q96DZ4 |